These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23674308)

  • 1. Most important outcomes research papers on treatment of stable coronary artery disease.
    Bikdeli B; Ranasinghe I; Chen R; Gupta A; Lampropulos JF; Kulkarni VT; Mody PS; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):e17-25. PubMed ID: 23674308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most important papers in health costs, cost-effectiveness, and resource utilization.
    Dharmarajan K; Lampropulos J; Bikdeli B; Mody P; Gupta A
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):e9-15. PubMed ID: 22438466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most important outcomes research papers on anticoagulation for cardiovascular disease.
    Bikdeli B; Gupta A; Mody P; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):e65-74. PubMed ID: 22991352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most important outcomes research papers in cardiovascular disease in the elderly.
    Gupta A; Mody P; Bikdeli B; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):e17-26. PubMed ID: 22592757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most important outcomes research papers on hypertension.
    Chen R; Dharmarajan K; Kulkarni VT; Punnanithinont N; Gupta A; Bikdeli B; Mody PS; Ranasinghe I
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):e26-35. PubMed ID: 23838106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most important articles on cardiovascular disease among racial and ethnic minorities.
    Mody P; Gupta A; Bikdeli B; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):e33-41. PubMed ID: 22811508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using electronic health records to predict costs and outcomes in stable coronary artery disease.
    Asaria M; Walker S; Palmer S; Gale CP; Shah AD; Abrams KR; Crowther M; Manca A; Timmis A; Hemingway H; Sculpher M
    Heart; 2016 May; 102(10):755-62. PubMed ID: 26864674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
    Mohammedi K; Préaubert N; Cariou T; Rigalleau V; Foussard N; Piazza L; Bairras-Martin C; Couffinhal T; Bezin J; Benard A
    Cardiovasc Diabetol; 2021 Mar; 20(1):63. PubMed ID: 33714278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of randomized studies of medical therapy vs revascularization for reducing rising costs of health care.
    Beller GA
    J Nucl Cardiol; 2009; 16(4):483-5. PubMed ID: 19562423
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal approaches to diabetic patients with multivessel disease.
    Razzouk L; Farkouh ME
    Trends Cardiovasc Med; 2015 Oct; 25(7):625-31. PubMed ID: 26398271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease.
    Giustino G; Dangas GD
    Prog Cardiovasc Dis; 2015; 58(3):306-15. PubMed ID: 26255239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.
    Birim Ö; Bogers AJ; Kappetein AP
    J Cardiovasc Surg (Torino); 2012 Oct; 53(5):641-50. PubMed ID: 22252542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention "dominates" coronary artery bypass graft surgery for high-risk patients: good news for patients, a challenge for healthcare planners.
    Radford MJ
    Circulation; 2006 Sep; 114(12):1229-31. PubMed ID: 16982950
    [No Abstract]   [Full Text] [Related]  

  • 14. Annual cost of stable coronary artery disease in France: A modeling study.
    Caruba T; Chevreul K; Zarca K; Cadier B; Juillière Y; Dubourg O; Sabatier B; Danchin N
    Arch Cardiovasc Dis; 2015 Nov; 108(11):576-88. PubMed ID: 26433733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the value of coronary artery computed tomography as the first-line anatomical test for stable patients with indications for invasive angiography due to suspected coronary artery disease. Initial cost analysis in the CAT-CAD randomized trial.
    Rudziński PN; Kruk M; Kępka C; Schoepf UJ; Otani K; Leonard TJ; Dębski M; Dzielińska Z; Pręgowski J; Witkowski A; Rużyłło W; Demkow M
    J Cardiovasc Comput Tomogr; 2020; 14(1):75-79. PubMed ID: 31780142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revascularization treatment of stable coronary artery disease.
    Magro M; Garg S; Serruys PW
    Expert Opin Pharmacother; 2011 Feb; 12(2):195-212. PubMed ID: 21226632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease: Implications for Value-Based Payment.
    Wadhera RK; Bhatt DL; Kind AJH; Song Y; Williams KA; Maddox TM; Yeh RW; Dong L; Doros G; Turchin A; Joynt Maddox KE
    Circ Cardiovasc Qual Outcomes; 2020 Apr; 13(4):e005977. PubMed ID: 32228065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) - a multicentre parallel-group randomised trial to compare early computerised tomography coronary angiography versus standard care in patients presenting with suspected or confirmed acute coronary syndrome: study protocol for a randomised controlled trial.
    Gray AJ; Roobottom C; Smith JE; Goodacre S; Oatey K; O'Brien R; Storey RF; Na L; Lewis SC; Thokala P; Newby DE
    Trials; 2016 Dec; 17(1):579. PubMed ID: 27923390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic methods in the century trial--a comprehensive lifestyle modification study for managing coronary artery disease.
    Langabeer JR; Delgado R; Lairson D; Johnson NP; Gould KL; Sdringola SM
    J Cardiovasc Transl Res; 2012 Jun; 5(3):333-6. PubMed ID: 22392001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
    Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D
    Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.